Activation of p53-dependent apoptosis by acute ablation of glycogen synthase kinase-3beta in colorectal cancer cells
- PMID: 15958644
- DOI: 10.1158/1078-0432.CCR-04-2624
Activation of p53-dependent apoptosis by acute ablation of glycogen synthase kinase-3beta in colorectal cancer cells
Abstract
Purpose: The restoration of checkpoint mechanisms may provide a rational anticancer approach, but the molecular circuitries of how this can be achieved therapeutically are poorly understood. A pivotal signaling network in colorectal cancer cells involves glycogen synthase kinase-3beta (GSK3beta), a multifunctional kinase whose role in tumor cell survival is not defined.
Experimental design: We used molecular, genetic, and pharmacologic antagonists of GSK3beta in p53+/+ or p53-/- colorectal cancer cells. We monitored kinase activity in immunoprecipitation, protein expression by immunoblotting, and cell death by multiparametric flow cytometry. A xenograft colorectal cancer model was used to study antitumor activity in vivo.
Results: Treatment of p53+/+ colorectal cancer cells with pharmacologic inhibitors of GSK3beta resulted in sustained elevation of p53, with up-regulation of p21(Waf1/Cip1) and loss of survivin levels. Molecular targeting of GSK3beta by overexpression of a GSK3beta dominant-negative mutant, or acute-silencing of GSK3beta by RNA interference, reproduced the induction of transcriptionally active p53 in colorectal cancer cells. This pathway was recapitulated by deregulated Wnt/T-cell factor signaling, with elevation of the tumor suppressor p14ARF, and reduced expression of the p53 antagonist, MDM2. Rather than cell cycle arrest, GSK3beta blockade resulted in p53-dependent apoptosis, which was contributed by acute loss of survivin and inhibition of colorectal cancer growth in mice.
Conclusions: Acute ablation of GSK3beta in colorectal cancer cells activates p53-dependent apoptosis and antagonizes tumor growth. This pathway may be exploited for rational treatment of colorectal cancer patients retaining wild-type p53.
Similar articles
-
Pharmacologic modulation of glycogen synthase kinase-3beta promotes p53-dependent apoptosis through a direct Bax-mediated mitochondrial pathway in colorectal cancer cells.Cancer Res. 2005 Oct 1;65(19):9012-20. doi: 10.1158/0008-5472.CAN-05-1226. Cancer Res. 2005. PMID: 16204075
-
Lithium activates the Wnt and phosphatidylinositol 3-kinase Akt signaling pathways to promote cell survival in the absence of soluble survival factors.Am J Physiol Renal Physiol. 2005 Apr;288(4):F703-13. doi: 10.1152/ajprenal.00189.2004. Epub 2004 Nov 30. Am J Physiol Renal Physiol. 2005. PMID: 15572521
-
Glycogen synthase kinase 3-dependent phosphorylation of Mdm2 regulates p53 abundance.Mol Cell Biol. 2005 Aug;25(16):7170-80. doi: 10.1128/MCB.25.16.7170-7180.2005. Mol Cell Biol. 2005. PMID: 16055726 Free PMC article.
-
Calcium, calcium-sensing receptor and colon cancer.Cancer Lett. 2009 Mar 8;275(1):9-16. doi: 10.1016/j.canlet.2008.07.001. Epub 2008 Aug 23. Cancer Lett. 2009. PMID: 18725175 Review.
-
Nitric oxide and p53 in cancer-prone chronic inflammation and oxyradical overload disease.Environ Mol Mutagen. 2004;44(1):3-9. doi: 10.1002/em.20024. Environ Mol Mutagen. 2004. PMID: 15199542 Review.
Cited by
-
Network Pharmacology and Bioinformatics Study of Geniposide Regulating Oxidative Stress in Colorectal Cancer.Int J Mol Sci. 2023 Oct 16;24(20):15222. doi: 10.3390/ijms242015222. Int J Mol Sci. 2023. PMID: 37894904 Free PMC article.
-
GSK-3β Allosteric Inhibition: A Dead End or a New Pharmacological Frontier?Int J Mol Sci. 2023 Apr 19;24(8):7541. doi: 10.3390/ijms24087541. Int J Mol Sci. 2023. PMID: 37108703 Free PMC article. Review.
-
Molecular docking, molecular dynamics simulations and in vitro screening reveal cefixime and ceftriaxone as GSK3β covalent inhibitors.RSC Adv. 2023 Apr 11;13(17):11278-11290. doi: 10.1039/d3ra01145c. eCollection 2023 Apr 11. RSC Adv. 2023. PMID: 37057264 Free PMC article.
-
Cross-Talk between p53 and Wnt Signaling in Cancer.Biomolecules. 2022 Mar 15;12(3):453. doi: 10.3390/biom12030453. Biomolecules. 2022. PMID: 35327645 Free PMC article. Review.
-
Tumor Suppressor Protein p53 and Inhibitor of Apoptosis Proteins in Colorectal Cancer-A Promising Signaling Network for Therapeutic Interventions.Cancers (Basel). 2021 Feb 4;13(4):624. doi: 10.3390/cancers13040624. Cancers (Basel). 2021. PMID: 33557398 Free PMC article. Review.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
Miscellaneous